Martin Cowie, of AstraZeneca, reviews the ESC's recently updated guidelines for HF and discusses Forxiga, an SGLT2 inhibitor. Dr. Ross Campbell discusses the OPERA-AI study results and how AI can be used to diagnose heart failure. Atrial fibrillation ablation is linked to lower rates of mortality and a decreased need for LVAD compared with therapy. Feeling safe from crime is linked to a lower risk of premature death and heart attack. Dr. Scott Solomon discussed a pooled analyses that assessed dapagliflozin in patients with heart failure and kidney disease.